Total Payments
$1,644
2024 Payments
$18.71
Companies
13
Transactions
90
Medicare Patients
225
Medicare Billing
$30,921
Payment Breakdown by Category
Food & Beverage$1,563 (95.0%)
Education$81.49 (5.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,563 | 89 | 95.0% |
| Education | $81.49 | 1 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $415.01 | 28 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $394.99 | 23 | $0 (2018) |
| Alkermes, Inc. | $200.40 | 10 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $142.58 | 6 | $0 (2018) |
| Lundbeck LLC | $93.12 | 2 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $92.27 | 2 | $0 (2022) |
| Allergan, Inc. | $87.74 | 6 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $77.43 | 5 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $60.52 | 3 | $0 (2018) |
| ABBVIE INC. | $35.63 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.71 | 1 | ABBVIE INC. ($18.71) |
| 2022 | $81.49 | 1 | Teva Pharmaceuticals USA, Inc. ($81.49) |
| 2021 | $16.92 | 1 | AbbVie Inc. ($16.92) |
| 2020 | $11.97 | 1 | Allergan, Inc. ($11.97) |
| 2019 | $14.35 | 1 | Allergan Inc. ($14.35) |
| 2018 | $452.21 | 27 | Otsuka America Pharmaceutical, Inc. ($135.19) |
| 2017 | $1,049 | 58 | Sunovion Pharmaceuticals Inc. ($281.98) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2022 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $81.49 | General |
| 11/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: CNS | ||||||
| 08/16/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Neuroscience | ||||||
| 07/31/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: PSYCHIATRY | ||||||
| 07/16/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: CNS | ||||||
| 07/10/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: CNS | ||||||
| 07/05/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: PSYCHIATRY | ||||||
| 05/22/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: CNS | ||||||
| 05/14/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: CNS | ||||||
| 05/02/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: NEUROLOGY | ||||||
| 04/23/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: CNS | ||||||
| 04/12/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: CNS | ||||||
| 02/27/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Neuroscience | ||||||
| 02/22/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: CNS | ||||||
| 02/15/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: CNS | ||||||
| 02/12/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.37 | General |
| Category: AED | ||||||
| 02/06/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 40 | 101 | $17,675 | $5,773 |
| 2022 | 1 | 45 | 129 | $22,575 | $7,148 |
| 2021 | 1 | 46 | 137 | $23,975 | $8,730 |
| 2020 | 3 | 94 | 212 | $38,010 | $9,269 |
Total Patients
225
Total Services
579
Medicare Billing
$30,921
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 101 | $17,675 | $5,773 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 129 | $22,575 | $7,148 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 137 | $23,975 | $8,730 | 36.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 152 | $26,600 | $6,362 | 23.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 26 | $5,460 | $1,910 | 35.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 34 | $5,950 | $997.72 | 16.8% |
About Dr. Douglas Ghrist, M.D
Dr. Douglas Ghrist, M.D is a Psychiatry healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1740474519.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Ghrist, M.D has received a total of $1,644 in payments from pharmaceutical and medical device companies, with $18.71 received in 2024. These payments were reported across 90 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,563).
As a Medicare-enrolled provider, Ghrist has provided services to 225 Medicare beneficiaries, totaling 579 services with total Medicare billing of $30,921. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Tyler, TX
- Active Since 09/05/2007
- Last Updated 05/06/2010
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1740474519
Products in Payments
- LATUDA (Drug) $415.01
- ABILIFY MAINTENA (Drug) $227.45
- Aristada 441 mg (Drug) $200.40
- REXULTI (Drug) $167.54
- VRAYLAR (Drug) $123.37
- INVEGA SUSTENNA (Drug) $114.79
- Fanapt (Drug) $77.43
- INGREZZA (Drug) $60.52
- INVEGA TRINZA (Drug) $27.79
- Trintellix (Drug) $21.33
- BELSOMRA (Drug) $11.84
- TROKENDI XR (Drug) $11.37
- AUSTEDO (Drug) $10.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Tyler
Gary Wilson, Md, MD
Psychiatry — Payments: $4,403
Psychiatry $4,403
Chance Mcinnis
Psychiatry — Payments: $4,281
Psychiatry $4,281
David Danly, Md, MD
Psychiatry — Payments: $4,150
Psychiatry $4,150
Igal Tarash, Do Md Emba, DO MD EMBA
Psychiatry — Payments: $734.11
Psychiatry $734.11
Phyllis Ramirez, Md, MD
Psychiatry — Payments: $712.87
Psychiatry $712.87
Andrew Oshiro, Md, MD
Psychiatry — Payments: $635.43
Psychiatry $635.43